Recent changes
Jump to navigation
Jump to search
Track the most recent changes to the wiki on this page.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
23 March 2025
| N 12:41 | Cefiderocol diffhist +6,676 Omid Afkhami-Ardakani talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=Omid AfkhamiArdakani |genericName=Cefiderocol |aOrAn=a |drugClass=Siderophore Cephalosporin Antibiotic |indicationType=treatment |indication=Complicated Urinary Tract Infections (cUTIs), Hospital-Acquired Bacterial Pneumonia (HABP), and Ventilator-Associated Bacterial Pneumonia (VABP) in adult patients. |hasBlackBoxWarning=Yes |adverseReactions=Diarrhea, Infusion site reactions, Constipation, Rash, Candidiasis (including...") | ||||
21 March 2025
| N 00:47 | Zanubrutinib diffhist +6,355 Omid Afkhami-Ardakani talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=Omid Afkhami-Ardakani |genericName=Zanubrutinib |aOrAn=a |drugClass=Bruton's Tyrosine Kinase (BTK) Inhibitor |indicationType=treatment |indication=Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Waldenström's Macroglobulinemia (WM), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL), and Follicular Lymphoma (FL) in adults. |adverseReactions=Decreased neutrophil count, Upper respiratory tract infection,...") | ||||
20 March 2025
| N 10:56 | Reblozyl diffhist +5,813 Omid Afkhami-Ardakani talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=Omid Afkhami-Ardakani |genericName=Luspatercept-aamt |aOrAn=an |drugClass=Erythroid Maturation Agent |indicationType=treatment |indication=anemia in adult patients. More specifically anemia due to Beta Thalassemia, Myelodysplastic Syndromes (MDS), MDS with Ring Sideroblasts (MDS-RS) or Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T). |adverseReactions=Fatigue, Headache, Musc...") | ||||
| N 10:20 | Vadadustat diffhist +19,544 Alara E. Dagsali talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag= Alara Ece Dagsali, M.D. |genericName=vadadustat |indicationType=treatment |indication=VAFSEO is indicated for the treatment of anemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least three months. |hasBlackBoxWarning=Yes |adverseReactions=*VAFSEO increases the risk of thrombotic vascular events, including major adverse cardiovascular events (MACE) *Targeting a hemoglobin lev...") | ||||
|
|
09:45 | Meningitis 3 changes history +943 [Alara E. Dagsali (3×)] | |||
|
|
09:45 (cur | prev) +2 Alara E. Dagsali talk contribs | ||||
|
|
09:44 (cur | prev) +39 Alara E. Dagsali talk contribs | ||||
|
|
08:54 (cur | prev) +902 Alara E. Dagsali talk contribs | ||||
19 March 2025
| 15:42 | Burnout (psychology) diffhist +1,343 Badgettrg talk contribs (→Leadership quality: Added Spilg) | ||||
18 March 2025
| N 20:58 | Danicopan diffhist +29,524 Alara E. Dagsali talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag= Alara Ece Dagsali, M.D. |genericName=Danicopan |aOrAn=a |drugClass=medication |indicationType=treatment |indication=VOYDEYA is indicated as add-on therapy to ravulizumab or eculizumab for the treatment of extravascular hemolysis (EVH) in adults with paroxysmal nocturnal hemoglobinuria (PNH). |hasBlackBoxWarning=Yes |adverseReactions=*Serious Infections Caused by Encapsulated Bacteria *Hepatic Enzyme Increase *Hyperl...") | ||||
| 20:39 | Alara E. Dagsali diffhist +69 Alara E. Dagsali talk contribs | ||||
| N 20:36 | Ceftobiprole medocaril sodium diffhist +36,115 Alara E. Dagsali talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag= Alara Ece Dagsali, M.D. |genericName=ceftobiprole medocaril sodium |aOrAn=a |drugClass=beta-lactam class of antibiotics |indicationType=treatment |indication='''1.1 Staphylococcus aureus Bloodstream Infection (Bacteremia)''' ZEVTERA is indicated for the treatment of adult patients with Staphylococcus aureus bloodstream infection (bacteremia) (SAB), including those with right-sided infective endocarditis, caused by me...") | ||||
|
|
N 19:50 | Pegulicianine 2 changes history +17,295 [Alara E. Dagsali (2×)] | |||
|
|
19:50 (cur | prev) +96 Alara E. Dagsali talk contribs | ||||
| N |
|
19:48 (cur | prev) +17,199 Alara E. Dagsali talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=User:AED |genericName=pegulicianine |aOrAn=a |drugClass=diagnostic imaging agent |indicationType=diagnosis |indication=LUMISIGHT is indicated for fluorescence imaging in adults with breast cancer as an adjunct for the intraoperative detection of cancerous tissue within the resection cavity following removal of the primary specimen during lumpectomy surgery. |hasBlackBoxWarning=Yes |adverseReactions=*Anaphylaxis and Other Serious Hyp...") | |||